Double-phase parathyroid 99mtc-sestamibi scintigraphy in chronic haemodialysis patients: correlation with biochemical markers of parathyroid function

Nuclear Medicine Communications

Volumn 24, Issue 1, 2003, Pages 85-90

  Fuster, D ^a   Ybarra, J ^a   Torregrosa, J V ^a   Setoain, X ^a   MartIn F ^a   Ortega, M L ^a   MartInez osaba M J ^a   Fuertes, S ^a   Pons, F ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

99mTc sestamibi scintigraphy; Haemodialysis; Parathormone; Parathyroid gland; Secondary hyperparathyroidism

Indexed keywords

25 HYDROXYVITAMIN D; 25-HYDROXYVITAMIN D; BIOLOGICAL MARKER; CALCIUM; DIAGNOSTIC AGENT; DIHYDROXYCOLECALCIFEROL; DRUG DERIVATIVE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; PARATHYROID HORMONE; PHOSPHORUS; RADIOPHARMACEUTICAL AGENT; VITAMIN D;

AGE; ARTICLE; BLOOD; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; COMPARATIVE STUDY; METABOLISM; PARATHYROID GLAND; RENAL REPLACEMENT THERAPY; REPRODUCIBILITY; SCINTISCANNING; SECONDARY HYPERPARATHYROIDISM; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; STATISTICS; VALIDATION STUDY;

AGE FACTORS; BIOLOGICAL MARKERS; CALCIUM; DIHYDROXYCHOLECALCIFEROLS; HYPERPARATHYROIDISM, SECONDARY; KIDNEY FAILURE, CHRONIC; PARATHYROID GLANDS; PARATHYROID HORMONE; PHOSPHORUS; RADIOPHARMACEUTICALS; RENAL DIALYSIS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SEX FACTORS; STATISTICS; TECHNETIUM TC 99M SESTAMIBI; VITAMIN D;

EID: 1842855722     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/00006231-200301000-00019     Document Type: Article

References (29)

1. Hruska KA, Teitelbaum SL. Mechanisms of disease: renal osteodystrophy. N Engl J Med 1995; 333: 166.
2. 99m-MIBI in isolated perfused rat hearts. J Nucl Med 1992; 33: 1516-1521.
3. Taillefer R, Boucher Y, Potvin C, et al. Detection and localization of parathyroid adenomas in patients with hyperparathyroidism using a single radionuclide imaging procedure with technetium-99m-sestamibi (double phase study). J Nucl Med 1992; 33: 1801-1807.
4. Caixàs A, Bernà L, Hernández A, et al. Efficacy of preoperative diagnostic imaging localization of technetium 99m-sestamibi scintigraphy in hyperparathyroidism. Surgery 1997; 121: 535-541.
5. Vallejos V, Martin-Comin J, Gonzalez MT, et al. The usefulness of Tc-99m tetrofosmin scintigraphy in the diagnosis and localisation of hyperfunctioning parathyroid glands. Clin Nucl Med 1999; 24: 959-964.
6. Takebayashi S, Hidai H, Chiba T, et al. Hyperfunctional parathyroid glands with 99mTc-MIBI scan: semiquantitative analysis correlated with histologic findings. J Nucl Med 1999; 40: 1792-1797.
7. Halvorson DJ, Burke GJ, Mansberger AR, et al. Use of technetium Tc 99m sestamibi and iodine 123 radionuclide scan for preoperative localization of abnormal parathyroid glands in primary hyperparathyroidism. South Med J 1994; 87: 336-339.
8. Kates DM, Sherrard DJ, Andress DL. Evidence that serum phosphate is independently associated with serum PTH in patients with chronic renal failure. Am J Kidney Dis 1997; 30: 809-813.
9. Hindie E, Melliere D, Perlemuter L, et al. Primary hyperparathyroidism: higher success rate of first surgery after preoperative Tc-99m sestamibi-I-123 subtraction scanning. Radiology 1997; 204: 221-228.
10. Ishibashi M, Nishida H, Hiromatsu Y, et al. Comparison of technetium-99m-MIBI, technetium-99m-tetrofosmin, ultrasound and MRI for localization of abnormal parathyroid glands. J Nucl Med 1998; 39: 320-324.
11. Pattou F, Oudar C, Huglo D, et al. Localisation of abnormal parathyroid glands with jugular sampling for parathyroid hormone, and subtraction scanning with sestamibi or tetrofosmin. Aust N Z J Surg 1998; 68: 108-111.
12. Takami H, Oshima M, Sugawara I, et al. Pre-operative localization and tissue uptake study in parathyroid imaging with 99mTc-sestamibi. Aust N Z J Surg 1999; 69: 629-631.
13. Valli N, Leccia F, Pommereau A, et al. Double-phase Tc-99m sestamibi scintigraphy in a patient with uremia and secondary hyperparathyroidism: an aid for subtotal parathyroidectomy. Clin Nucl Med 1999; 24: 189-191.
14. Neumann DR, Esselstyn CB, Madera A, et al. Parathyroid detection in secondary hyperparathyroidism with 123I/99mTc-sestamibi subtraction single photon emission computed tomography. J Clin Endocrinol Metab 1998; 83: 3867-3871.
15. Hindie E, Urena P, Jeanguillaume C, et al. Preoperative imaging of parathyroid glands with technetium 99m-labeled sestamibi and iodine-123 subtraction scanning in secondary hyperparathyroidism. Lancet 1999; 353: 2200-2204.
16. Casanova D, Sarfati E, De Francisco A, et al. Secondary hyperparathyroidism: diagnosis of site of recurrence. World J Surg 1991; 15: 546-548.
17. Rodriquez JM, Tezelman S, Siperstein AE, et al. Localization procedures in patients with persistent or recurrent hyperparathyroidism. Arch Surg 1994; 129: 870-873.
18. Pons F, Torregrosa JV, Vidal-Sicart S. Preoperative parathyroid gland localization with technetium-99m sestamibi in secondary hyperparathyroidism. Eur J Nucl Med 1997; 24: 1494-1498.
19. Olaizola I, Zingraff J, Heuguerot C, et al. 99mTc-sestamibi parathyroid scintigraphy in chronic haemodialysis patients: static and dynamic explorations. Nephrol Dial Transplant 2000; 15: 1201-1206.
20. Chen H, Civelek AC, Westra WH, et al. Use of technetium Tc 99m sestamibi scintigraphy for recurrent tertiary hyperparathyroidism from a parathyroid forearm graft. South Med J 2000; 93: 215-217.
21. Llach F. Secondary hyperparathyroidism in renal failure: the trade-off hypothesis revisited. Am J Kidney Dis 1995; 25: 663-679.
22. Slatopolsky E, Bricker NS. The role of phosphorus restriction in the prevention of secondary hyperparathyroidism in chronic renal disease. Kidney Int 1973; 4: 141-144.
23. Llach F, Massry SG. On the mechanism of secondary hyperparathyroidism in moderate renal insufficiency. J Clin Endocrinol Metab 1985; 61: 601-604.
24. Almaden Y, Hernandez A, Torregrosa V, et al. High phosphate level directly stimulates parathyroid hormone secretion and synthesis by human parathyroid tissue in vitro. J Am Soc Nephrol 1998; 9: 1845-1852.
25. Torregrosa JV, Fernandez-Cruz L, Canalejo A, et al. 99mTc-sestamibi scintigraphy and cell cycle in parathyroid glands of secondary hyperparathyroidism. World J Surg 2000; 24: 1386-1390.
26. Irvin GL, Prudhomme DL, Deriso GT, et al. A new approach to parathyroidectomy. Ann Surg 1994; 219: 579-581.
27. Torregrosa JV, Pons F, Sabater L, et al. Has double-phase MIBI scintigraphy usefulness in the diagnosis of hyperparathyroidism? Nephrol Dial Transplant 1998; 13: 37-40.
28. Piga M, Bolasco P, Satta L, et al. Double-phase parathyroid technetium-99m-MIBI scintigraphy to identify functional autonomy in secondary hyperparathyroidism. J Nucl Med 1996; 37: 565-569.
29. Mischis-Trossard C, Goudet P, Verges B, et al. Primary hyperparathyroidism with normal serum intact parathyroid hormone levels. Q J Med 2000; 93: 365-367.